KR101733723B1 - 전기화학적으로 활성화된 차아염소산염 용액을 포함하는 약제학적 제제 - Google Patents

전기화학적으로 활성화된 차아염소산염 용액을 포함하는 약제학적 제제 Download PDF

Info

Publication number
KR101733723B1
KR101733723B1 KR1020157020110A KR20157020110A KR101733723B1 KR 101733723 B1 KR101733723 B1 KR 101733723B1 KR 1020157020110 A KR1020157020110 A KR 1020157020110A KR 20157020110 A KR20157020110 A KR 20157020110A KR 101733723 B1 KR101733723 B1 KR 101733723B1
Authority
KR
South Korea
Prior art keywords
administration
composition according
electrochemically activated
composition
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020157020110A
Other languages
English (en)
Korean (ko)
Other versions
KR20150093244A (ko
Inventor
미란 배로니안
Original Assignee
아자드 파르마 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아자드 파르마 아게 filed Critical 아자드 파르마 아게
Publication of KR20150093244A publication Critical patent/KR20150093244A/ko
Application granted granted Critical
Publication of KR101733723B1 publication Critical patent/KR101733723B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/10—Halogens or compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/10—Halogens or compounds thereof
    • A61L12/107—Hypohalites; Active halogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005—Other compounding ingredients characterised by their effect
    • C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/395—Bleaching agents
    • C11D3/3956—Liquid compositions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/40—Specific cleaning or washing processes
    • C11D2111/46—Specific cleaning or washing processes applying energy, e.g. irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020157020110A 2007-07-26 2008-07-28 전기화학적으로 활성화된 차아염소산염 용액을 포함하는 약제학적 제제 Expired - Fee Related KR101733723B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95203507P 2007-07-26 2007-07-26
US60/952,035 2007-07-26
US98818107P 2007-11-15 2007-11-15
US60/988,181 2007-11-15
PCT/EP2008/006193 WO2009013019A2 (en) 2007-07-26 2008-07-28 Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020107003555A Division KR101633449B1 (ko) 2007-07-26 2008-07-28 전기화학적으로 활성화된 치아염소산염 용액을 포함하는 약제학적 제제

Publications (2)

Publication Number Publication Date
KR20150093244A KR20150093244A (ko) 2015-08-17
KR101733723B1 true KR101733723B1 (ko) 2017-05-10

Family

ID=40239573

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020107003555A Expired - Fee Related KR101633449B1 (ko) 2007-07-26 2008-07-28 전기화학적으로 활성화된 치아염소산염 용액을 포함하는 약제학적 제제
KR1020157020110A Expired - Fee Related KR101733723B1 (ko) 2007-07-26 2008-07-28 전기화학적으로 활성화된 차아염소산염 용액을 포함하는 약제학적 제제

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020107003555A Expired - Fee Related KR101633449B1 (ko) 2007-07-26 2008-07-28 전기화학적으로 활성화된 치아염소산염 용액을 포함하는 약제학적 제제

Country Status (10)

Country Link
US (1) US20100266710A1 (enExample)
EP (1) EP2178501B1 (enExample)
JP (1) JP5872159B2 (enExample)
KR (2) KR101633449B1 (enExample)
CN (2) CN101778621B (enExample)
AU (1) AU2008280437B2 (enExample)
CA (1) CA2694929C (enExample)
ES (1) ES2671372T3 (enExample)
RU (1) RU2554802C2 (enExample)
WO (1) WO2009013019A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2374762T3 (pl) 2010-03-31 2013-04-30 Caliopa Ag Układ i sposób do wytwarzania elektrochemicznie aktywowanego roztworu
CN102971262A (zh) * 2010-03-31 2013-03-13 卡里欧帕股份公司 电化学活化的水基溶液及该溶液的用途
EP2422792A1 (de) 2010-08-26 2012-02-29 Caliopa AG Elektrochemisch aktivierte Lösung auf Wasserbasis und Verwendung der Lösung
EP2431056A1 (de) 2010-09-16 2012-03-21 Caliopa AG Pharmazeutische Zusammensetzung, enthaltend elektrochemisch aktivierte Salzlösung
EP2543359A1 (de) * 2011-07-08 2013-01-09 Caliopa AG Gel zur Verwendung in einem Wundbehandlungsmittel
EP2567689A1 (en) * 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
US8771753B2 (en) * 2011-09-16 2014-07-08 Zurex Pharmagra, Llc Systems and methods for generating germicidal compositions
US10617716B2 (en) * 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions
JPWO2018074421A1 (ja) * 2016-10-21 2019-08-29 ライオン株式会社 眼科用剤及び眼科用薬
WO2019101352A1 (de) 2017-11-27 2019-05-31 Sanixtreme Gmbh & Co. Kg Formulierung zur bildung eines desinfizierenden schaums
EP3593862A1 (en) * 2018-07-12 2020-01-15 Azad Pharma AG Electrochemically activated salt solution
EP3919047A1 (en) * 2020-06-03 2021-12-08 AZAD Pharma AG Microemulsion for the treatment of dry eye syndrome
WO2022081297A1 (en) * 2020-10-12 2022-04-21 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for lowering intracranial pressure by intranasal agent administration

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521362A (ja) 2003-03-27 2006-09-21 アラーガン、インコーポレイテッド 保存眼科用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
JPH10236961A (ja) * 1997-02-25 1998-09-08 Nobel Igaku Kenkyusho:Kk 電解酸性水を用いた眼科用剤
EP1123119A1 (en) * 1998-10-23 2001-08-16 Radical Waters IP (PTY) Ltd Method for applying bactericidal solutions
WO2000033757A1 (en) * 1998-12-09 2000-06-15 Advanced H¿2?O Inc. A system for decontamination of dental unit waterlines using electrolyzed water
RU2148027C1 (ru) * 1999-02-01 2000-04-27 Бахир Витольд Михайлович Способ получения дезинфицирующего раствора - нейтрального анолита анд
US7393522B2 (en) * 2000-01-12 2008-07-01 Novabay Pharmaceuticals, Inc. Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
EP1251878A2 (en) * 2000-02-04 2002-10-30 Radical Waters IP (PTY) Ltd Dental equipment and method of operating such equipment
RU2180605C1 (ru) * 2000-07-24 2002-03-20 Завод "Автоматика" Способ внутриушной ультразвуковой терапии хронических средних отитов
EP1501530B1 (en) * 2002-03-21 2009-02-18 Cayman Chemical Company Prostaglandin f2 alpha analogs in combination with antimicrobial for treating glaucoma
US20050139808A1 (en) * 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
EP1809237B1 (en) * 2004-11-09 2008-12-31 Novagali Pharma SA Ophthalmic oil-in-water type emulsion with stable positive zeta potential
BRPI0609711B8 (pt) * 2005-03-23 2021-05-25 Oculus Innovative Sciences Inc uso de uma solução aquosa com potencial redutivo oxidativo (orp)
CN101336113B (zh) * 2005-11-28 2015-07-29 千寿制药株式会社 包括ppar激动剂的药物
AU2007205861B2 (en) * 2006-01-20 2013-05-09 Oculus Innovative Sciences, Inc. Methods of treating or preventing sinusitis with oxidative reductive potential water solution

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521362A (ja) 2003-03-27 2006-09-21 アラーガン、インコーポレイテッド 保存眼科用組成物

Also Published As

Publication number Publication date
US20100266710A1 (en) 2010-10-21
EP2178501A2 (en) 2010-04-28
JP5872159B2 (ja) 2016-03-01
WO2009013019A2 (en) 2009-01-29
CN101778621A (zh) 2010-07-14
EP2178501B1 (en) 2018-05-02
RU2554802C2 (ru) 2015-06-27
CA2694929C (en) 2016-10-18
ES2671372T3 (es) 2018-06-06
AU2008280437A1 (en) 2009-01-29
CN101778621B (zh) 2015-09-09
CA2694929A1 (en) 2009-01-29
KR20150093244A (ko) 2015-08-17
KR101633449B1 (ko) 2016-06-24
RU2010107043A (ru) 2011-09-10
AU2008280437B2 (en) 2012-11-29
JP2010534629A (ja) 2010-11-11
CN105213299A (zh) 2016-01-06
KR20100051817A (ko) 2010-05-18
WO2009013019A3 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
KR101733723B1 (ko) 전기화학적으로 활성화된 차아염소산염 용액을 포함하는 약제학적 제제
EP0976407A1 (en) Antiseptic composition
CA2737263A1 (en) Mucomimetic compositions and uses therefore
NO339109B1 (no) Konserverende sammensetning for oftalmisk anvendelse
KR20190126135A (ko) 소독용 조성물
KR20100017168A (ko) Ｎ-할로겐화 아미노산 제제 및 세정 및 소독 방법
TWI393567B (zh) 治療乾眼之組合物及相關之製造方法及使用方法
JP2935339B2 (ja) 外用消毒液
CA2758858C (en) Aqueous ophthalmic compositions containing anionic therapeutic agents
AU2009288277B2 (en) Pharmaceutical composition having relatively low ionic strength
WO2012034659A2 (de) Pharmazeutische zusammensetzung, enthaltend elektrochemisch aktivierte salzlösung
JP4892291B2 (ja) 眼科用防腐組成物
JP2004203867A (ja) 眼科用保存剤
WO2006127121A2 (en) Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
JPH06293638A (ja) 安定なビタミンａ類点眼剤
WO2004052403A1 (ja) 眼科用保存剤

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PE0801 Dismissal of amendment

St.27 status event code: A-2-2-P10-P12-nap-PE0801

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

Fee payment year number: 4

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 5

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PC1903 Unpaid annual fee

Not in force date: 20220429

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20220429

St.27 status event code: N-4-6-H10-H13-oth-PC1903

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000